Kemper Corp Master Retirement Trust’s AbbVie ABBV Stock Holding History

Kemper Corp Master Retirement Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,800	Closed	-$621K	–	4
2020 Q4	$621K	Sell	5,800 -2,500	-30%	-$240K	0.39%	32
2020 Q3	$727K	Sell	8,300 -12,550	-60%	-$1.18M	0.43%	32
2020 Q2	$2.05M	Sell	20,850 -4,100	-16%	-$361K	0.92%	26
2020 Q1	$2.05M	Hold	24,950	–	–	0.93%	26
2019 Q4	$2.21M	Sell	24,950 -8,500	-25%	-$706K	1.02%	28
2019 Q3	$2.53M	Hold	33,450	–	–	1.26%	28
2019 Q2	$2.43M	Hold	33,450	–	–	1.48%	28
2019 Q1	$2.7M	Hold	33,450	–	–	1.71%	23
2018 Q4	$3.08M	Hold	33,450	–	–	2.2%	14
2018 Q3	$3.16M	Sell	33,450 -5,900	-15%	-$560K	2.02%	15
2018 Q2	$3.65M	Hold	39,350	–	–	2.48%	14
2018 Q1	$3.72M	Sell	39,350 -1,950	-5%	-$214K	2.94%	13
2017 Q4	$3.99M	Hold	41,300	–	–	2.27%	15
2017 Q3	$3.67M	Hold	41,300	–	–	2.2%	15
2017 Q2	$3M	Hold	41,300	–	–	1.86%	17
2017 Q1	$2.69M	Sell	41,300 -4,200	-9%	-$264K	1.76%	17
2016 Q4	$2.85M	Hold	45,500	–	–	1.78%	15
2016 Q3	$2.87M	Hold	45,500	–	–	1.78%	19
2016 Q2	$2.82M	Hold	45,500	–	–	1.77%	18
2016 Q1	$2.6M	Hold	45,500	–	–	1.34%	18
2015 Q4	$2.69M	Hold	45,500	–	–	1.42%	16
2015 Q3	$2.48M	Hold	45,500	–	–	1.22%	18
2015 Q2	$3.06M	Hold	45,500	–	–	1.36%	15
2015 Q1	$2.66M	Hold	45,500	–	–	1.18%	19
2014 Q4	$2.98M	Hold	45,500	–	–	1.32%	18
2014 Q3	$2.63M	Hold	45,500	–	–	1.04%	24
2014 Q2	$2.57M	Hold	45,500	–	–	0.93%	26
2014 Q1	$2.34M	Hold	45,500	–	–	0.88%	29
2013 Q4	$2.4M	Hold	45,500	–	–	0.87%	28
2013 Q3	$2.04M	Hold	45,500	–	–	0.81%	29
2013 Q2	$1.88M	Buy	+45,500	New	+$1.99M	0.82%	31

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kemper Corp Master Retirement Trust's ABBV Position: Q1 2021 in Review

Kemper Corp Master Retirement Trust sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 5,800 shares — an estimated $621K sold.

Kemper Corp Master Retirement Trust first reported a position in ABBV in Q2 2013 and held it in 31 quarters. The position peaked at $3.99M in Q4 2017. 2,615 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

Kemper Corp Master Retirement Trust reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
Kemper Corp Master Retirement Trust sold 5,800 AbbVie shares in Q1 2021, an estimated $621K.
Kemper Corp Master Retirement Trust first reported a position in AbbVie in Q2 2013 and held it in 31 quarters.
Kemper Corp Master Retirement Trust's AbbVie position peaked at $3.99M in Q4 2017.
2,615 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on Kemper Corp Master Retirement Trust's 13F filing for Q1 2021, filed 11 May 2021.